BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS)

CUSIP: G11217117

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / CLASS A ORD SHS
Total 13F shares
22,095,858
Share change
+1,112,796
Total reported value
$230,673,906
Price per share
$10.44
Number of holders
60
Value change
+$12,176,103
Number of buys
16
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP G11217117?
CUSIP G11217117 identifies BIOS - BIOPLUS ACQUISITION CORP - CLASS A ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS) as of Q1 2023

As of 31 Mar 2023, BIOPLUS ACQUISITION CORP - CLASS A ORD SHS (BIOS) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,095,858 shares. The largest 10 holders included ARISTEIA CAPITAL LLC, Westchester Capital Management, LLC, CANTOR FITZGERALD, L. P., Polar Asset Management Partners Inc., PICTON MAHONEY ASSET MANAGEMENT, Saba Capital Management, L.P., Calamos Advisors LLC, Linden Advisors LP, METEORA CAPITAL, LLC, and D. E. Shaw & Co., Inc.. This page lists 60 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.